This site is intended for healthcare professionals outside of the United States (US) and the United Kingdom (UK).
This site is created and funded by Novartis.
Radioligand therapy (RLT) stands at the forefront of modern cancer treatment, offering hope to patients through targeted nuclear medicine. Yet, the journey to deliver RLT can be long and complex for prescribing and treating physicians.
Radioligand therapy (RLT) stands at the forefront of modern cancer treatment, offering hope to patients through targeted nuclear medicine. Yet, the journey to deliver RLT can be long and complex for prescribing and treating physicians.
RLTCare: where expertise, convenience, reliability, and unwavering support converge to enable better patient outcomes.
Partnering with centers to assess RLT readiness
We empower you and your teams with the latest knowledge and skills to confidently prescribe and treat with RLT.
Plan and modify RLT orders effortlessly
With such a time-critical treatment, we make it seamless to plan, modify, or cancel RLT doses for your patients through our flexible and convenient online ordering platform—helping you focus on what matters most: patient care.
Ensuring reliable treatment deliveries
Producing RLT at scale is a precise and time-sensitive process, and we understand that patients cannot afford disruptions to their care. That is why we have established a robust global manufacturing footprint and supply chain, ensuring reliable and consistent delivery of our products.
Providing expert assistance
Whether you have a question about dose delivery or need urgent technical expertise, we are on-hand to provide direct assistance through our comprehensive customer support system—helping you deliver reliable, consistent, and effective RLT.
With RLTCare, excellent customer service is not just a promise—it is a priority
Get In Touch
Our dedicated RLT specialist teams aim to streamline care coordination and alleviate uncertainty, ensuring you and your patients feel confident and supported every step of the way.